Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Document:EU 2011/C 172/01 - CT-3 11-Jun-2011

From GxPlex

Revision as of 15:07, 29 June 2026 by Gxplex admin (talk | contribs) (1 revision imported)
Jump to: navigation, search


Document information
Reference EU 2011/C 172/01 -

CT-3 11-Jun-2011

Validity area EU
Scope(s) G
Document name 2011/C 172/01 -

CT-3

Version / Revision 11-Jun-2011
Status Current
Document type Regulatory requirement
Language(s) EN
Description Communication from the Commission — Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human use ( ‘CT-3’ )
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


References

Reference Scope Document part Language Preview
Reference:EU 2011/C 172/01 - CT-3 11-Jun-2011 Section 7 7.3.1 G Section 7

7.3.1 || EN || Communication from the Commission — Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human ...

Reference:EU 2011/C 172/01 - CT-3 11-Jun-2011 Section 7 7.3.2 G Section 7

7.3.2 || EN || Communication from the Commission — Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human ...

Reference:EU 2011/C 172/01 - CT-3 11-Jun-2011 Section 7 7.3.3 G Section 7

7.3.3 || EN || Communication from the Commission — Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human ...